| pioglitazone / Generic mfg. |
PPAR-G, NCT00819325: Prevention of Instent Renarrowing With Aggressive Glucose Lowering With Pioglitazone in Diabetic Patients |
|
|
| Completed | 4 | 50 | Canada | pioglitazone, oral hypoglycemic agents | Queen Elizabeth II Health Sciences Centre, Nova Scotia Health Research Foundation | Coronary Artery Disease, Angina Pectoris, Type 2 Diabetes Mellitus, Percutaneous Coronary Intervention | 11/06 | 03/07 | | |
| Completed | 4 | 92 | Europe | pioglitazone, placebo | IKFE Institute for Clinical Research and Development, Takeda, Johannes Gutenberg University Mainz, Heidelberg University | Type 2 Diabetes Mellitus, Cardiovascular Disease | | 11/06 | | |
NCT00494559: The Effect of Pioglitazone on Neointima Volume and Inflammatory Markers |
|
|
| Completed | 4 | 240 | RoW | Pioglitazone, Actos, Placebo | Korea University Anam Hospital | Diabetes Mellitus, Coronary Artery Stenosis | 07/08 | 07/15 | | |
NCT01588470: Myocardial Dysfunction in Type 2 Diabetes Mellitus (T2DM) |
|
|
| Completed | 4 | 130 | NA | pioglitazone, Actos | The University of Texas Health Science Center at San Antonio, Takeda Pharmaceuticals North America, Inc. | Type 2 Diabetes, Coronary Heart Disease | 12/11 | 12/11 | | |
NCT01331967: The Effect of Pioglitazone on Neointima Volume and Characteristics Observed by Optical Coherence Tomography (OCT) |
|
|
| Completed | 4 | 94 | RoW | Pioglitazone | Korea University Anam Hospital | Diabetic Stable Angina, Diabetic Unstable Angina | 02/13 | 08/13 | | |
